Clinical Trial: Study of a Cohort of Children With Molluscum Contagiosum (MC) Treated With a 5% Solution of Potassium Hydroxide (Molutrex®) Applied Locally to the Skin
Study Status: Completed
Recruit Status: RECRUITING
Condition: Molluscum Contagiosum
Study Type: OBSERVATIONAL
Official Title: Multicenter National Observational and Prospective Study of a Cohort of Children With Molluscum Contagiosum (MC) Treated With a 5% Solution of Potassium Hydroxide (Molutrex®) Applied Locally to the Sk
Brief Summary:
Molutrex® a 5% potassium hydroxide solution for topical application to the skin.Molutrex® is intended for the superficial treatment of certain types of warts, molluscum contagiosum and is composed of potassium hydroxide (5%) purified water.With regard to the 2017/745 RDM, he is a class IIa medical device.In accordance with Regulation (EU) 2017/745 of the European Parliament and of the Council of April 5, 2017 relating to medical devices, as part of the Molutrex® Post-Marketing Monitoring Plan, the…
Read more